MAGEA3 rHuz mAb (Ref: CT Atlantic patent)
Application
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Reactivity
Human
Target
| Target Name | MAGEA3 |
| Target Uniprot | P43357 |
Overview
| Catalog# | BIO0225SM |
| Product Name | Anti-human MAGEA3 (CT Atlantic patent Anti-MAGE-A3 Biosimilar) |
Specifications
| Conjugation | None |
| Formulation | 100 mM Pro-Ac 20mM Arg pH 5.0 |
| Storage | For long term storage, the produce should be stored at -20℃ or lower. |
| Reconstitution | Dissolve with sterile ddH2O |
| Concentration | Lot Dependent |
| Isotype | Human IgG1 |
| Calculated M.W. | 150 kDa |
| Endotoxin | <0.001 EU/ug |
| Expression System | CHO |
| Purification | Protein A |
Frequently asked questions
Which applications is MAGEA3 rHuz mAb (Ref: CT Atlantic patent) (BIO0225SM) validated for, and at what dilution?
BIO0225SM is validated for In Vivo Research.